UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023438
Receipt number R000027007
Scientific Title A Procedureless Intra-gastric Diet Balloon Capsule
Date of disclosure of the study information 2016/08/05
Last modified on 2020/02/14 12:37:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Procedureless Intra-gastric Diet Balloon Capsule

Acronym

A Swallowable Balloon Capsule for Bariatric Therapy (BCBT)

Scientific Title

A Procedureless Intra-gastric Diet Balloon Capsule

Scientific Title:Acronym

A Swallowable Balloon Capsule for Bariatric Therapy (BCBT)

Region

Japan


Condition

Condition

Obesity

Classification by specialty

Medicine in general Gastroenterology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To establish a non-invasive, patient-friendly and simple bariatric therapy for preventing comorbidities due to obesity.

Basic objectives2

Others

Basic objectives -Others

To validate that this method is so efficient as at reducing body weight as conventional intra-gastric bariatric balloons implanted using endoscopic assistance.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Reducing rate of the excess body weight before and after the trial

Key secondary outcomes

1. Reducing the amount of internal fat tissue which will be evaluated by a CT scan before and after the trial.
2. Efficacy of glucose tolerance and hyperlipidemia 16 weeks after ingestion
3.Changes in the microbiota in the gut using 16S rRNA fecal analysis 16 weeks after ingestion
4.Evaluation of adverse reactions


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Two arm cross-over trial
Arm1: A swallowable balloon capsule (volume 400ml filled with CO2) implanted for 4 months in the stomach
Arm2: A placebo balloon capsule ( not inflatable due to holes in it ) is ingested

Interventions/Control_2

4 months later after excreting the first balloon,
Arm1: placebo balloon capsule.
Arm2: real swallowable balloon capsule

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1.Patients with a BMI more than 30
2.Patients with a BMI between 25 and 30 who have a past history of, or are presently having treatment for diabetes, hyperlipidemia (LDL-C over 200), angina pectoris, cerebral infarction or NASH (Non- alcoholic steatohepatitis).

Key exclusion criteria

1. Patients undergoing insulin therapy or patients with conditions such as chronic heart failure or chronic renal failure, which would make it very difficult for them to improve physical activity levels.
2. Patients who cannot ingest capsules
3. Patients who have a rubber allergy
4. Patients who have their digestive tract altered by surgery or have a high risk of ileus or stenosis due to stricture in the gastrointestinal tract.
5. Patients who have an implant such as a cardiac pace-maker.
6. Patients who will not allow the doctor to perform an endoscopic procedure in an emergency.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidetoshi Ohta

Organization

Sapporo Orthopaedics and Cardiovascular Hospita

Division name

Gastroenterology

Zip code


Address

1-2-11-30 Kitano, Kiyota-ku,

TEL

011-881-1100

Email

hideohta@true.ocn.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masami Sasaki

Organization

Sapporo Orthopaedics and Cardiovascular Hospital

Division name

Committee for Clinical Trial and Institutional Review Board

Zip code


Address

1-2-11-30 Kitano, Kiyota-ku, Sapporo, Japan

TEL

011-881-1100

Homepage URL


Email

sasaki26314@yahoo.co.jp


Sponsor or person

Institute

Sapporo Orthopaedics and Cardiovascular Hospital

Institute

Department

Personal name



Funding Source

Organization

Sapporo Orthopaedics and Cardiovascular Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Sapporo Shiroishi Memorial Hospital,
Otaru Ekisaikai Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

札幌整形循環器病院(北海道)、札幌白石記念病院(北海道)、小樽掖済会病院(北海道)


Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 07 Day

Date of IRB

2016 Year 04 Month 30 Day

Anticipated trial start date

2016 Year 08 Month 05 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2019 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 05 Month 01 Day


Other

Other related information



Management information

Registered date

2016 Year 08 Month 01 Day

Last modified on

2020 Year 02 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027007


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name